Australian University Rankings Guide

Infectious Disorders: Drug Targets (ERA Journal)

Infectious Disorders: Drug Targets is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Infectious Disorders: Drug Targets issns are issn1: 1871-5265 issn2: 2212-3989.

The fields covered by Infectious Disorders: Drug Targets as part of the evaluation of Australian university research excellence are:

Microbiology Research Rankings (Sub-Field)

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Microbiology field include:

- Antimicrobial Agents and Chemotherapy
- Antimicrobial Resistance and Infection Control
- Archivum Immunologiae et Therapiae Experimentalis
- Environmental Microbiology Reports
- Genome Announcements
- Geomicrobiology Journal: an international journal of geomicrobiology and microbial biogeochemistry
- International Journal of Food Microbiology
- International Journal of Leprosy and Other Mycobacterial Diseases
- Journal of AOAC International
- Journal of Basic Microbiology: an international journal on biochemistry physiology genetics morphology and ecology of microorganisms
- Journal of Biology and Life Sciences
- Journal of Molecular Biology
- Microbiology and Immunology
- Mycosystema
- The Internet Journal of Microbiology

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4